WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013054338) 2-THIO-IMIDAZOLE DERIVATIVES AS TGR5 MODULATORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/054338    International Application No.:    PCT/IN2012/000471
Publication Date: 18.04.2013 International Filing Date: 04.07.2012
Chapter 2 Demand Filed:    30.01.2013    
IPC:
C07D 233/84 (2006.01), C07D 403/12 (2006.01), C07D 405/12 (2006.01), C07D 409/12 (2006.01), A61K 31/4178 (2006.01), A61K 31/4164 (2006.01), A61P 3/04 (2006.01)
Applicants: CADILA HEALTHCARE LIMITED [IN/IN]; Zydus Tower, Satellite Cross Road Ahmedabad 380015 Gujarat (IN) (For All Designated States Except US).
AGARWAL, Sameer [IN/IN]; (IN) (For US Only).
JAIN, Mukul R [IN/IN]; (IN) (For US Only).
PATEL, Pankaj R [IN/IN]; (IN) (For US Only)
Inventors: AGARWAL, Sameer; (IN).
JAIN, Mukul R; (IN).
PATEL, Pankaj R; (IN)
Agent: SUBRAMANIAM, Hariharan; Subramaniam, Nataraj & Associates E-556, Greater Kailash-II New Delhi 110048 (IN)
Priority Data:
1947/MUM/2011 06.07.2011 IN
Title (EN) 2-THIO-IMIDAZOLE DERIVATIVES AS TGR5 MODULATORS
(FR) DÉRIVÉS DE 2-THIOL-IMIDAZOLE UTILES COMME MODULATEURS DE TGR5
Abstract: front page image
(EN)The present invention relates to compounds of the general Formula I their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, enantiomers, diastereomers, prodrugs, their N-oxide, metabolites, polymorphs, use of these compounds in medicine for treating diabetes (TGR5 modulators) and the intermediates involved in their preparation.
(FR)La présente invention concerne des composés de la formule générale (I), leurs sels pharmaceutiquement acceptables, leurs solvates pharmaceutiquement acceptables, des énantiomères, des diastéréomères, des promédicaments, leur N-oxyde, des métabolites, des polymorphes, l'utilisation de ces composés en médecine pour traiter le diabète (modulateurs de TGR5) et les intermédiaires employés dans leur préparation.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)